Reduction of tumorigenicity by an interferon-γ-gene-transduced tumor on another syngeneic tumor in a murine model

Surgery Today

Volumn 29, Issue 4, 1999, Pages 338-343

  Ichinose, You ^a   Okino, Takashi ^a   Yamasaki, Seiji ^a   Moriguchi, Yoshio ^a   Sugie, Tomoharu ^a   Li, Li ^a   Kanaoka, Shunji ^a   Kan, Norimichi ^a   Watanabe, Yoshihiko ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antitumor immunity; Immunological memory; Interferon ; Retroviral gene transfer

Indexed keywords

GAMMA INTERFERON; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER IMMUNOTHERAPY; CARCINOGENICITY; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNOLOGICAL MEMORY; MALE; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REJECTION;

EID: 0032910606     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02483058     Document Type: Article

References (22)

1. Hori T, Kan N, Ohgaki K, Yamazaki N, Nakayama N, Nio Y, Inamoto T (1984) Tumor-specific cytotoxicity of tumor infiltrating lymphocytes (TIL) induced with TCGF in murine mammary carcinoma (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 85:749-757
2. Watanabe Y (1994) Tumorigenicity and immunogenicity of IFN-gamma producing tumor cells. In: Forni G, Foa R, Santoni AL, Frati L (eds) Cytokine-induced tumor immunogenicity. From exogenous molecules to gene therapy. Academic Press, London, pp 233-247
3. Teramura Y, Watanabe Y, Kan N, Masuda T, Kuribayashi K (1993) Interferon-gamma-producing tumor induces host tumor-specific T cell responses. Jpn J Cancer Res 84:689-696
4. Mineshita T, Yamaguchi K (1965) An androgen-dependent mouse mammary tumor. Cancer Res 25:1168-1174
5. Watanabe Y, Sakata T (1988) Highly efficient action of autocrine mouse interferon-gamma expressed via a retroviral vector. Eur J Immunol 18:1627-1630
6. Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E, Taniyama T, Sakata T (1989) Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA 86:9456-9460
7. Ichinose Y, Okino T, Yamasaki S, Sugie T, Li L, Kanaoka S, Kan N, Imamura M (1998) Analysis of IFN-gamma synthesis by IFN-gamma-gene-transduced-tumor-cell using extraction fluid obtained from sponge implant (in Japanese with English abstract). Biotherapy 12:191-193
8. Spitalny GL, Havell EA (1984) Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 159:1560-1565
9. Yanagihara K, Seyama T, Watanabe Y (1994) Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity. Nat Immun 13:102-112
10. Lollini PL, Bosco MC, Cavallo F, De Giovanni C, Giovarelli M, Landuzzi L, Musiani P, Modesti A, Nicoletti G, Palmieri G, Santoni A, Young HA, Forni G, Nanni P (1993) Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer 55:320-329
11. Esumi N, Hunt B, Itaya T, Frost P (1991) Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression. Cancer Res 51:1185-1189
12. Maluish AE, Urba WJ, Longo DL, Overton WR, Coggin D, Crisp ER, Williams R, Sherwin SA, Gordon K, Steis RG (1988) The determination of an immunologically active dose of interferon-gamma in patients with melanoma. J Clin Oncol 6:434-445
13. Farrar MA, Schreiber RD (1993) The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11:571-611
14. d antigens by splenic lymphocytes. J Immunol 146:1858-1861
15. Freedman AS, Freeman GJ, Rhynhart K, Nadler LM (1991) Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 137:429-437
16. Glick RP, Lichtor T, Kim TS, Ilangovan S, Cohen EP (1995) Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce antitumor immunity to a murine glioma in vivo. Neurosurgery 36:548-555
17. Lehmann F, Marchand M, Hainaut P, Pouillart P, Sastre X, Ikeda H, Boon T, Coulie PG (1995) Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol 25:340-347
18. Kohara N, Kitaoka F, Komuta K, Yamamoto M, Motojima K, Kanematsu T (1995) Effective treatment of liver metastases from colon cancer with a combination of gamma-interferon and cisplatin chemotherapy: report of a case. Surg Today 25:357-360
19. Pujade-Lauraine E, Guastalla JP, Colombo N, Devillier P, Francois E, Fumoleau P, Monnier A, Nooy M, Mignot L, Bugat R, Marques C, Mousseau M, Netter G, Maloisel F, Larbaoui S, Brandely M (1996) Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy. J Clin Oncol 14:343-350
20. Cantell K, Fiers W, Hirvonen S, Phyala L (1984) Circulating interferon in rabbits after simultaneous intramuscular administration of human alpha and gamma interferon. J Interferon Res 4:291-293
21. Wiesenfeld M, O'Connell MJ, Wieand HS, Gonchoroff NJ, Donohue JH, Fitzgibbons RJ Jr, Krook JE, Mailliard JA, Gerstner JB, Pazdur R (1995) Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer. J Clin Oncol 13:2324-2329
22. Abdel-Wahab Z, Weltz C, Hester D, Pickett N, Vervaert C, Barber JR, Jolly D, Seigler HF (1997) A phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response. Cancer 80:401-412